Latest Manufacturing News

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

VRX Silica Limited has raised $2.1 million through a share placement to fund critical pre-construction activities at its Arrowsmith North Silica Sand Project, aiming to strengthen its position in high-quality silica sand markets.

Element 25 Limited is making significant strides in expanding its Butcherbird Manganese Mine, securing $60 million in funding and advancing critical engineering and contract milestones to boost manganese concentrate production to 1.1 million tonnes per annum.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Zeotech Limited’s AusPozz™ has been independently validated by BG&E as a high-performance, low-carbon supplementary cementitious material, showing remarkable strength gains and durability benefits in concrete applications.

Lithium Universe advances its U.S. solar panel recycling strategy following silver’s historic classification as a Critical Metal, positioning itself to tap into soaring demand and a growing PV waste stream.

Yugo Metals has finalised preparations and signed a contract to commence its inaugural gold-focused diamond drilling at the Sinjakovo project, aiming to validate promising earlier exploration results.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Sea Forest Limited launches a $20.5 million IPO on the ASX to scale production and commercialisation of SeaFeed™, a scientifically validated livestock feed additive that cuts methane emissions by up to 80% while boosting productivity.

Alfabs Australia Limited reported robust financial gains in FY2025, including a maiden dividend and major contract completion, while signaling cautious optimism for 2026 amid softer markets and uncertain project pipelines.